REMEDY has received €50,000 in funding through the BOOST program – Bringing financial support to innOvation and pOrtfolio activitieS increasing impact, to enhance its involvement in EIC-supported research.
This funding supports REMEDY’s participation in PATH2ELMs, a strategic initiative aimed at aligning with the goals of the ELMs Strategic Plan. Through this initiative, REMEDY will actively contribute to key portfolio activities and help advance innovative technologies in the ELMs field. The PATH2ELMs consortium comprises four partners from three EU countries- Slovenia, Austria, and the Netherlands – including: InnoRenew CoE, Tiger Coatings, Graz University of Technology, and Xylhotrade. The initiative is structured into four key phases and will run until March 31, 2027.
